功能高分子材料教育部重点实验室

近期发表论文
当前位置: 首页 > 科技创新 > 近期发表论文 > 正文

郭术涛课题组 | JOURNAL OF NANOBIOTECHNOLOGY

发布人:    发布时间:2020/10/30   浏览次数:

Interaction kinetics of peptide lipids-mediated gene delivery

Zhao, YN (Zhao, Yinan)[ 1 ] ; Zhao, TY (Zhao, Tianyi)[ 2 ] ; Du, YY (Du, Yanyan)[ 1 ] ; Cao, YN (Cao, Yingnan)[ 1 ] ; Xuan, Y (Xuan, Yang)[ 1 ] ; Chen, HY (Chen, Huiying)[ 1 ] ; Zhi, DF (Zhi, Defu)[ 1 ] ; Guo, ST (Guo, Shutao)[ 3,4 ] ; Zhong, FL (Zhong, Fangli)[ 5 ] ; Zhang, SB (Zhang, Shubiao)[ 1 ]

JOURNAL OF NANOBIOTECHNOLOGY, 2020, 18(1), 文献号: 144

DOI: 10.1186/s12951-020-00707-1

摘要

Background: During the course of gene transfection, the interaction kinetics between liposomes and DNA is speculated to play very important role for blood stability, cellular uptake, DNA release and finally transfection efficiency.

Results: As cationic peptide liposomes exhibited great gene transfer activities both in vitro and in vivo, two peptide lipids, containing a tri-ornithine head (LOrn3) and a mono-ornithine head (LOrn1), were chosen to further clarify the process of liposome-mediated gene delivery in this study. The results show that the electrostatically-driven binding between DNA and liposomes reached nearly 100% at equilibrium, and high affinity of LOrn3 to DNA led to fast binding rate between them. The binding process between LOrn3 and DNA conformed to the kinetics equation: y = 1.663631 x exp (- 0.003427x) + 6.278163. Compared to liposome LOrn1, the liposome LOrn3/DNA lipoplex exhibited a faster and more uniform uptake in HeLa cells, as LOrn3 with a tri-ornithine peptide headgroup had a stronger interaction with the negatively charged cell membrane than LOrn1. The efficient endosomal escape of DNA from LOrn3 lipoplex was facilitated by the acidity in late endosomes, resulting in broken carbamate bonds, as well as the "proton sponge effect" of the lipid.

Conclusions: The interaction kinetics is a key factor for DNA transfection efficiency. This work provided insights into peptide lipid-mediated DNA delivery that could guide the development of the next generation of delivery systems for gene therapeutics.